Latest total revenue for BDR: $18M, below the Technology sector average of $38T.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2022
Trailing 12 months ending Dec 2022
Blonder Tongue Laboratories posts a total revenue of $18M as of December 2022. That compares with $16M in the prior-year period — up 11.1% year over year. That is below the Technology sector average of $38T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Blonder Tongue Laboratories's total revenue was $16M. The latest reading is $18M — a 11.1% year-over-year increase (period ending December 2022). Use the history and growth charts on this page for a longer lookback.
For Technology stocks, a total revenue near $38T is typical. Blonder Tongue Laboratories's $18M is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Total Revenue is one piece of Blonder Tongue Laboratories's financial statement story. At $18M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for BDR's total revenue usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $38T), and (3) consistency with growth and profitability. This page covers the first two; Blonder Tongue Laboratories's other metric pages and overview cover the third.